[ad_1] bei Novartis sind die Geschäfte auch im dritten Quartal 2018 erfolgreich verlaufen. Vor germ dank deutlich gestiegener Umsätze in der Pharmasparte hat das Unternehmen denn auf für das Gesamtjahr die Umsatzerwartungen …
Read More »Novartis flatters Donald Trump – News Economy: Business
[ad_1] According to Pfizer Novartis is the second pharmaceutical company to waive the surtaxes planned for the second semester and to congratulate the US president. "We are putting a lot of pressure …
Read More »Novartis defends against US Senate allegations in the Cohen case
[ad_1] Novartis is breathing new life against American lawyer Michael Cohen. According to US senators, the pharmaceutical company made misleading statements about its cooperation with Cohen. Novartis denies the conclusions. 13.7.2018, 16:21 …
Read More »Fighting resistant germs: Novartis stops the development of antibiotics
[ad_1] Multidrug-resistant germs are spreading more and more. At the same time, major pharmaceutical companies are withdrawing from antibiotic research. Novartis also halted the development of significant resources. By Christian Baars and …
Read More »Implenia Primal Affentranger Leaves – Novartis Man Comes
[ad_1] It is the end of an era: for twelve years, Anton Affentranger (61 years old) has been running the business of Implenia. At the end of September, he leaves his office …
Read More »Novartis Man succeeds Implenia Primal Affentranger
[ad_1] The change of leadership is not a surprise. Affentranger has already announced early 2016 that he wants to resign in two years at the head of Implenia. The board of directors …
Read More »The decommissioning of Novartis by Moody & # 39; s shows that the pharmaceutical industry is no longer as defensive
[ad_1] Comment In the stock market, the pharmaceutical company Novartis received many applause for the split of Alcon. But observers of Moody's solvency are worried for a good reason, Novartis delaying debt …
Read More »